Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06839664
PHASE3

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.

Official title: A Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

610

Start Date

2024-11-11

Completion Date

2026-02-27

Last Updated

2025-02-21

Healthy Volunteers

No

Interventions

DRUG

HS-20094 injection

Administered SC

DRUG

Placebo injection

Administered SC

Locations (1)

Peking University People's Hospital

Beijing, Beijing Municipality, China